Incyte (INCY) Free Cash Flow (2010 - 2026)

Incyte (INCY) reported Free Cash Flow of $359.2 million for Q1 2026, up 36.61% on a YoY basis from $262.9 million in Q1 2025, and down 26.49% quarter-over-quarter from $488.6 million in Q4 2025.

Incyte (INCY) Free Cash Flow (2010 - 2026) Analysis & Trends

Incyte has reported Free Cash Flow for 17 years, with the latest figure at $359.2 million in Q1 2026.

  • For the quarter ending Q1 2026, Free Cash Flow rose 36.61% year-over-year to $359.2 million; the trailing twelve-month figure through Mar 2026 stood at $1.5 billion (up 284.64% YoY), and the FY2025 full-year result was $1.4 billion, up 307.11% from the prior year.
  • Free Cash Flow for Q1 2026 stood at $359.2 million, down from $488.6 million in the prior quarter.
  • The five-year high for Free Cash Flow was $559.3 million in Q3 2025, with the low at -$576.0 million in Q2 2024.
  • Historically, Free Cash Flow has averaged $204.5 million across 5 years, with a median of $262.9 million in 2025.
  • The largest YoY upside for Free Cash Flow was 285.88% in 2024 against a maximum downside of 292.51% in 2024.
  • Incyte's Free Cash Flow stood at $336.7 million in 2022, then sank by 65.77% to $115.3 million in 2023, then surged by 231.58% to $382.2 million in 2024, then advanced by 27.85% to $488.6 million in 2025, then fell by 26.49% to $359.2 million in 2026.
  • The last three Free Cash Flow figures came in at $359.2 million (Q1 2026), $488.6 million (Q4 2025), and $559.3 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -1.67 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -12.20 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -2.49 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 1.29 Bn
9 Abivax 91.96 Bn 91.96 Bn - 63,220.27
10 Incyte 19.62 Bn 15.60 Bn 1.17 Bn 359.15 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 359.15 Mn
Mar 31, 2026 359.15 Mn
Dec 31, 2025 488.59 Mn
Dec 31, 2025 488.59 Mn
Sep 30, 2025 559.28 Mn
Sep 30, 2025 559.28 Mn
Jun 30, 2025 43.86 Mn
Jun 30, 2025 43.86 Mn
Mar 31, 2025 262.90 Mn
Mar 31, 2025 262.90 Mn
Dec 31, 2024 382.16 Mn
Dec 31, 2024 382.16 Mn
Sep 30, 2024 308.13 Mn
Sep 30, 2024 308.13 Mn
Jun 30, 2024 -575.98 Mn
Jun 30, 2024 -575.98 Mn
Mar 31, 2024 218.43 Mn
Mar 31, 2024 218.43 Mn
Dec 31, 2023 115.25 Mn
Dec 31, 2023 115.25 Mn